chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Scratch, Speech disorder, Vomiting
Clinical narrative: I actually blacked out./But the blackout was scary; trouble sleeping; fevered; sick feeling; don't remember much from Friday morning at all; threw up the tylenol; scratches; could not form coherent sentences; This is a spontaneous report from a contactable consumer (patient). This 33-year-old  non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 22Apr2021 16:15 (Batch/Lot Number: EW0169) as DOSE 2, SINGLE (at the age of 33 years) for covid-19 immunisation.  Historical vaccine included BNT162B2 for Covid-19 immunization as DOSE 1 SINGLE (at the age of 33 years) on 01Apr2021 16:30 in the right arm Brand: Pfizer Lot number: ER8732 and experienced insomnia.  The patient had no other vaccine other than BNT162B2 in four weeks. The patient medical history was not reported. The patient reported she did not have any known allergies.  The patient did not have Covid prior vaccination.  Concomitant medications included topiramate (TOPAMAX) taken for an unspecified indication, start and stop date were not reported; paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported.  The patient experienced "I actually blacked out./but the blackout was scary " on 23Apr2021 04:00 with outcome of recovered, trouble sleeping on 23Apr2021 04:00 with outcome of recovered , got up at 4am running a fever on 23Apr2021 04:00 with outcome of recovered, sick feeling on 23Apr2021 04:00 with outcome of recovered, threw up the Tylenol on 23Apr2021 with outcome of recovered, scratches on 23Apr2021 with outcome of recovered, could not form coherent sentences on 23Apr2021 with outcome of recovered, "don't remember much from Friday morning at all" on 23Apr2021 with outcome of recovered, "The next thing I remember is my dog waking me up by licking my face about 20 mins later. I was laying face down in the hallway between the bathroom and the bedroom. Other than some scratches, I didn't get hurt. I also could not form coherent sentences while trying to call my husband to tell him to come home from work. I don't remember much from Friday morning at all. It is all a fog. But the blackout was scary. I was fevered and sick feeling for 24 hours and then was fine again."   The patient underwent lab tests and procedures which included body temperature: fever on 23Apr2021.  Therapeutic measures were taken as a result of fevered (Tylenol).  Fever and sick feeling resolved on 24Apr2021.  All other events recovered in 2021. The patient did not have a Covid test-post-vaccination.    No follow-up attempts are required. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021458876 same reporter/patient, different vaccine dose and event
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling on the left side of collarbone, believe it is the lymph node; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8731) via an unspecified route of administration in the left arm on 22Apr2021 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included loratadine (CLARITIN) from an unknown date for an unspecified indication and unknown if ongoing. On 24Apr2021, the patient experienced swelling on the left side of collarbone, he believed it was the lymph node and this was on the same side as the injection. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swelling on the left side of collarbone, believe it was the lymph node was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Next morning dizzy and nausea 4 days then less for 6 days and then nausea and dizzy since then.; Next morning dizzy and nausea 4 days then less for 6 days and then nausea and dizzy since then.; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 09:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Mar2021 at 13:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. On 06Apr2021 at 07:00, the next morning after the vaccination, the patient experienced dizzy and nausea 4 days, then less for 6 days and then nausea and dizzy since then. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received prednisone and meclizine as treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy and nausea were not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Lymph node swelling the size of a golf ball inleft armpit; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 24Apr2021 at 10:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included birth control medication from unknown date and for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on 03Apr2021 at 14:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 05:00 the patient experienced lymph node swelling the size of a golf ball in left armpit. On 19Apr2021 the patient underwent for COVID-19 virus test (nasal swab) and the results were found to be negative. Therapeutic measures were not taken as the result of event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event lymph node swelling the size of a golf ball in left armpit was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Sensitive skin
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 12:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included obsessive compulsive disorder (OCD) and chronic urticaria (not current). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and norethisterone acetate/ethinylestradiol/ferrous fumarate (LOMEDIA 24 FE), both taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 12:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 23:00, the patient experienced overall strong body achiness, headache and skin sensitivity. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events overall strong body achiness, headache and skin sensitivity was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Left ear - fluttering sound when exposed to any type of sound; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 09:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos disease and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), vitamin b nos (VITAMIN B) and folic acid (MANUFACTURER UNKNOWN); all on unknown date for unspecified indication. On 19Apr2021, the patient experienced left ear fluttering sound when exposed to any type of sound. No therapeutic measures were taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left ear fluttering sound when exposed to any type of sound was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash papular, Vaccination site pain
Clinical narrative: Red, itchy bumps at location of the shot and in elbow.; Soreness came back in location of the shot and in forearm; Soreness came back in location of the shot and in forearm; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 at 13:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medications included lamotrigine (LAMICTAL) and venlafaxine hydrochloride (EFFEXOR); taken from unknown dates for unknown indications and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 13:00, the patient experienced red, itchy bumps at location of the shot and in elbow and soreness came back in location of the shot and in forearm. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red, itchy bumps at location of the shot and in elbow and soreness came back in location of the shot and in forearm was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: "Vomtting"; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25Apr2021 at 09:00, the patient experienced "vomtting". The clinical outcome of the event "vomtting" was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: Left side of tongue started to tingle like it was going to go numb then, left side of lip up to left jaw all started to tingle; Left side of tongue started to tingle like it was going to go numb then, left side of lip up to left jaw all started to tingle; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified vitamins and "MAPs amino's"; both taken for unknown indications from an unknown date and unknown if ongoing. On 06Apr2021 at 13:00, the patient's left side of tongue started to tingle like it was going to go numb then, left side of lip up to left jaw all started to tingle like it tingles when it starts to wake up from being numb at the dentist. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL (recommended by pharmacist to take-as reported). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left side of tongue started to tingle like it was going to go numb then, left side of lip up to left jaw all started to tingle were recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: Hives of right wrist after second dose; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 28Apr2021 at 11:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 05Apr2021 at 17:30 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 30Apr2021 at 09:00, the patient experienced hives of right wrist after second dose. Therapeutic measures were not taken as a result of the adverse event. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The patient had underwent COVID-19 Ag CARD test (nasal swab) on 23Apr2021 and the result was negative. The clinical outcome of the event hives of right wrist was recovering at the time of this report.  No follow-up attempts are needed. Information about lot number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Toothache
Clinical narrative: The next day I experienced tooth pain at the site of a previous root canal.; Fogginess; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 64-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 12:00, the patient experienced fogginess, fatigue. On 17Apr2021, the next day she experienced tooth pain at the site of a previous root canal. Therapeutic measures were not taken as a result of these events. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fogginess, fatigue, tooth pain and pain was recovered on 19Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: Sore arm muscle; Overall body achiness; sore arm; This is a spontaneous report from a contactable consumer. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via intramuscular route of administration in the left arm on 23Apr2021 at 10:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received concomitant medications within 2 weeks of vaccination which are not specified. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 02Apr2021 at 14:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 19:00, the patient experienced sore arm muscle and overall body achiness. Therapeutic measures were taken as a result of the adverse event sore arm muscle and overall body achiness included the treatment with acetaminophen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm muscle and body achiness were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Lymphadenopathy, Pain in extremity, Vaccination site pain
Clinical narrative: Injection site pain; Joint pain; Swollen lymph nodes under left arm; Arm pain; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration in the left arm on 23Apr2021 at 15:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control pill from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 15:45 as a single dose for COVID-19 immunisation. On 24Apr2021 at 09:00, the patient experienced injection site pain, joint pain, swollen lymph nodes under left arm, arm pain and tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ADVIL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, joint pain, swollen lymph nodes under left arm, arm pain and tiredness were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very sore arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 14:30 hours (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient experienced very sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very sore arm was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain, Pain in extremity
Clinical narrative: Sore arm; feeling run down; body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 13:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and montelukast sodium (SINGULAIR), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 13:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 18:00, the patient experienced sore arm, feeling run down and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events sore arm, feeling run down and body aches were resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Nausea, Pyrexia
Clinical narrative: Flu-like symptoms (fever, nausea, and headache); Flu-like symptoms (fever, nausea, and headache); Flu-like symptoms (fever, nausea, and headache); Flu-like symptoms (fever, nausea, and headache); This is a spontaneous report from a contactable consumer. A non-pregnant female patient with an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 28Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. On 29Apr2021 a day after receiving the second dose of the Pfizer COVID-19 vaccine, the patient experienced flu-like symptoms (fever, nausea, and headache). Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu-like symptoms (fever, nausea, and headache) was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pollakiuria, Pyrexia
Clinical narrative: Fever up to 101 F Degreefrom the day vaccination; Urinating frequently (10 times in aday); Heavy body pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 12:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of COVID -19 vaccine. On 26Apr2021 at 17:00, the patient experienced "fever up to 101 F Degree from the day vaccination till now, urinating frequently; 10 times in a day, heavy body pains". The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 26Apr2021, the patient underwent Body temperature and the result was fever up to 101 F Degree. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "fever up to 101 F Degree from the day vaccination till now, urinating frequently; 10 times in a day, heavy body pains" was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaginal discharge, Vaginal haemorrhage
Clinical narrative: Watery and bloody vaginal discharge, two weeks ahead of my menstrual cycle; Watery and bloody vaginal discharge, two weeks ahead of my menstrual cycle; This is a spontaneous report from a contactable pharmacist (patient). A 37-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0167), via an unspecified route of administration, administered in Arm Left on 27Apr2021 (at the age of 37-year-old) as dose 1, single for covid-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing Depression, hyperlipidemia (both controlled) , hyperlipidaemia from an unknown date and unknown if ongoing Depression, hyperlipidemia (both controlled). Concomitant medications included fluoxetine taken for an unspecified indication, start and stop date were not reported; atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Apr2021, the patient experienced watery and bloody vaginal discharge, two weeks ahead of my menstrual cycle. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date, if covid prior vaccination Yes. No treatment was taken as a result of events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Speech disorder
Clinical narrative: It became difficult to breath and speak.; It became difficult to breath and speak.; This is a spontaneous report from a non-contactable consumer reported for herself that: A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 13:00 (Batch/Lot Number: ER8737) as DOSE 1, SINGLE for covid-19 immunization. The patient past Medical history included chronic sinusitis from an unknown date and unknown if ongoing, Known allergies: shellfish and ibuprofen. There were no concomitant medications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient has not received other medications in two weeks. The patient experienced it became difficult to breath and speak on 03Apr2021 13:15. The patient is treated with Benadryl and Allergy tests- allergic vaccine. The events result in Doctor or other healthcare professional office/clinic visit. The event outcome was Unknown.  No follow-up attempts are Possible. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Decreased appetite, Headache, Oropharyngeal pain
Clinical narrative: Sore throat; Terrible stomachaches; Decreased appetite; Very bad headache; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 11:30 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included anxiety, depression and gluten sensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced very bad headache for two days, terrible stomach aches that were still occurring non-stop after eight days and decreased appetite. On 19Apr2021, two days after the vaccination, the patient experienced sore throat.  The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very bad headache was recovered on 19Apr2021. The clinical outcome of the event sore throat was recovered on 21Apr2021. The clinical outcome of the events terrible stomach aches and decreased appetite were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Insomnia, Restless legs syndrome
Clinical narrative: Uneasy feeling like restless leg syndrome but in entire body.; Uneasy feeling like restless leg syndrome but in entire body; Can not sleep; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 04:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), salbutamol (ALBUTEROL), atorvastatin (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. On 23Apr2021 at 22:30, the patient experienced uneasy feeling like restless leg syndrome but in entire body and she could not sleep because of it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Any therapeutic measures were not taken for the reported events. The clinical outcome of the events uneasy feeling like restless leg syndrome but in entire body and can not sleep was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Oropharyngeal pain
Clinical narrative: right side of neck feels like slept on it wrong; right side of throat hurts to swallow; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 11:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa based drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) from unknown date for an unknown indication and unknown if ongoing. The patient previously took codeine (MANUFACTURER UNKNOWN) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021 at 19:00, the patient experienced right side of neck feels like slept on it wrong and right side of throat hurts to swallow. It was reported that injection was given in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right side of neck feels like slept on it wrong and right side of throat hurts to swallow was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation, Throat tightness
Clinical narrative: constructed, scratchy throat; constructed, scratchy throat; This is a spontaneous report from a contactable consumer or other non-health care professional. A 63 year age old male patient received bnt162b2 (Pfizer BIONTECH covid-19 vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 26Mar2021 13:30 (Lot Number: ER8727) as dose 2, single for covid-19 immunisation. Medical history included , from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took BNT162B2, Dose 1, Lot number: EN6206, for covid-19 immunisation on 05Mar2021, 12:30 PM. The patient experienced constructed, scratchy throat, constructed, scratchy throat on 27Mar2021. It was sometimes worse (splitting). My husband 63; (same date/batch) and I both have had a constructed, scratchy Throat since taking the shot. Really should warn people. It is now over 30 days. No COVID prior vaccination and no COVID tested post vaccination. Non allergic. The outcome of events was not recovered.   No follow-up attempt are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of unknown age received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Feb2021 as a single dose for COVID-19 immunisation. It was unknown whether the patient had any relevant medical history. It was unknown whether the patient was allergic to any medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient received any medications within two weeks of vaccination. On an unknown date in Feb2021, the patient experienced sore arm. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. S The clinical outcome of the event sore arm was recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain
Clinical narrative: Light headedness; Soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 09:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021 at 11:00, the patient experienced light headedness and soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events light headedness and soreness were recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Very swollen lymph node near collar bone on right side, so far lasting more than 2 weeks after first dose (is currently visibly swollen).; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8729) via an unspecified route of administration in the right arm on 09Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. The patient had received concomitant medication within two weeks of vaccination which included birth control pill (unspecified) on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced very swollen lymph node near collar bone on right side, so far at the time of report lasting more than two weeks after first dose and was currently visibly swollen. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event very swollen lymph node near collar bone on right side, so far at the time of report lasting more than two weeks after first dose and was currently visibly swollen was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Pain in extremity, Sleep disorder, Swelling
Clinical narrative: have pain when I lift my left arm; hot flashes at night; experiencing sleeplessness. I used tofall asleep very easily, now I wake upmultiple times at night from the hotflashes (every 1-2 hours); Under arm (armpit) swollen ever since; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced the under arm (armpit) swollen ever since. On an unknown date in May2021, 3 weeks later, the patient had pain when he lifted his left arm. On 19Apr2021, the patient experienced hot flashes at night and experienced sleeplessness ever since. It was reported that the patient used to fall asleep very easily and later the patient used to wake up multiple times at night from the hot flashes every 1-2 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events under arm (armpit) swollen, pain when lifted left arm, hot flashes at night, sleeplessness was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node swelling in underarm; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm right on 24Apr2021 at 15:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 24Apr2021 at 18:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 25Apr2021, about 24hrs after the dose 2 injection, the patient developed lymph node swelling in underarm and the side effect had been very low so far. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lymph node swelling in the underarm was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling (pins and needles) in left hand, Left foot and Right hand. Occasional tingling in tongue/ Pins and needles in left calf. and left arm.; Pain behind left knee; Numb fingers left hand.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 (at the age of 43-year-old) as a single dose for COVID-19 immunization. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient had tingling (pins and needles) in left hand, left foot and right hand. The patient had occasional tingling in tongue, pain behind left knee and numb fingers of left hand. The patient also had pins and needles in left calf and left arm. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling (pins and needles) in left hand, left foot and right hand, occasional tingling in tongue, pain behind left knee, numb fingers of left hand, pins and needles in left calf and left arm was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected